Current Medicinal Chemistry

Molecular Modeling Approaches in the Discovery of New Drugs for Anti-Cancer Therapy: The Investigation of p53-MDM2 Interaction and its Inhibition by Small Molecules
pp. 3142-3154(13)
Authors: Lauria, A.; Tutone, M.; Ippolito, M.; Pantano, L.; Almerico, A. M.

Histone Variant H2A.Z Can Serve as a New Target for Breast Cancer Therapy
pp. 3155-3161(7)
Author: Rangasamy, D.

Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis
pp. 3162-3214(53)
Authors: Kontogiorgis, C.; Hadjipavlou-Litina, D.

The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy
pp. 3215-3222(8)
Authors: Hirotani, M.; Niino, M.; Sasaki, H.

Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
pp. 3223-3229(7)
Authors: Takai, S.; Jin, D.; Miyazaki, M.

Development of Specific Inhibitors of CYP707A, a Key Enzyme in the Catabolism of Abscisic Acid
pp. 3230-3244(15)
Authors: Todoroki, Y.; Ueno, K.

Defining Cell Identity by Comprehensive Gene Expression Profiling
pp. 3245-3252(8)
Authors: Toyoda, M.; Hamatani, T.; Okada, H.; Matsumoto, K.; Saito, H.; Umezawa, A.

Hyperhomocysteinemia in L-Dopa Treated Patients with Parkinson's Disease: Potential Implications in Cognitive Dysfunction and Dementia?
pp. 3253-3261(9)
Authors: Zoccolella, S.; Lamberti, S. V.; Iliceto, G.; Santamato, A.; Lamberti, P.; Logroscino, G.

A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
pp. 3262-3288(27)
Authors: Wojcik, M.; Burzynska-Pedziwiatr, I.; Wozniak, L. A.

In Vitro Synergistic Action of Certain Combinations of Gentamicin and Essential Oils
pp. 3289-3295(7)
Authors: Rosato, A.; Piarulli, M.; Corbo, F.; Muraglia, M.; Carone, A.; Vitali, M. E.; Vitali, C.